PC-26 35 High/Low	PC-26 Value	ProbeId	Name	Aliases	Description	Function	Protein Families	
high	8.87103602899	214063_s_at	TF	PRO1557;PRO2086	transferrin	ferric iron binding (GO:0008199);iron ion binding (GO:0005506);iron ion homeostasis (GO:0006879);iron ion transport (GO:0006826);transport (GO:0006810)	Bipartite nuclear localization signal (IPR001472);Peptidase S60, transferrin lactoferrin (IPR001156)	
high	7.69280342352	201820_at	KRT5	CK5;EBS2;KRT5;KRT5A	keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types)	structural constituent of cytoskeleton (GO:0005200)	AMP-dependent synthetase and ligase (IPR000873);Intermediate filament protein (IPR001664);Keratin, type I (IPR002957);Type II keratin (IPR003054)	
high	7.6742737104	207935_s_at	KRT13	CK13;K13;KRT13;MGC3781	keratin 13	structural constituent of cytoskeleton (GO:0005200)	Intermediate filament protein (IPR001664);Keratin, type I (IPR002957)	
high	7.40910568425	203400_s_at	TF	PRO1557;PRO2086	transferrin	ferric iron binding (GO:0008199);iron ion binding (GO:0005506);iron ion homeostasis (GO:0006879);iron ion transport (GO:0006826);transport (GO:0006810)	Bipartite nuclear localization signal (IPR001472);Peptidase S60, transferrin lactoferrin (IPR001156)	
high	6.38400079055	212464_s_at	FN1	CIG;FINC;FN1;LETS;MSF	fibronectin 1	acute-phase response (GO:0006953);cell adhesion (GO:0007155);cell migration (GO:0016477);collagen binding (GO:0005518);extracellular matrix structural constituent (GO:0005201);heparin binding (GO:0008201);response to wounding (GO:0009611)	Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472);EGF-like domain (IPR006209);Fibronectin, type I (IPR000083);Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Type II fibronectin collagen-binding domain (IPR000562)	
high	6.24594929649	202283_at	SERPINF1	EPC-1;PEDF;SERPINF1	serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1	cell proliferation (GO:0008283);development (GO:0007275);histogenesis and organogenesis (GO:0007397);neurogenesis (GO:0007399);serine-type endopeptidase inhibitor activity (GO:0004867);serpin (GO:0004868)	Proteinase inhibititor I4, serpin (IPR000215);Surface protein from Gram-positive cocci, anchor region (IPR001899)	
high	6.21092115167	201983_s_at	EGFR	EGFR;ERBB;ERBB1	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)	ATP binding (GO:0005524);cell proliferation (GO:0008283);electron transport (GO:0006118);electron transporter activity (GO:0005489);epidermal growth factor receptor activity (GO:0005006);epidermal growth factor receptor signaling pathway (GO:0007173);iron ion binding (GO:0005506);protein amino acid phosphorylation (GO:0006468);receptor activity (GO:0004872);transferase activity (GO:0016740)	Epidermal  growth-factor receptor (EGFR), L domain (IPR000494);Furin-like cysteine rich region (IPR006211);Growth factor, receptor (IPR009030);Protein kinase (IPR000719);Serine/threonine protein kinase (IPR002290);Tyrosine protein kinase (IPR001245)	
high	5.99671246396	205820_s_at	APOC3	APOC3	apolipoprotein C-III	apolipoprotein (GO:0005320);lipid binding (GO:0008289);lipid catabolism (GO:0016042);lipid metabolism (GO:0006629);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);lipoprotein metabolism (GO:0042157);plasma protein (GO:0005209)	Apolipoprotein CIII (IPR008403)	
high	5.95700187155	206130_s_at	ASGR2	ASGP-R;ASGR2;Hs.1259;L-H2	asialoglycoprotein receptor 2	asialoglycoprotein receptor activity (GO:0004873);biological_process unknown (GO:0000004);cell surface receptor linked signal transduction (GO:0007166);endocytosis (GO:0006897);heterophilic cell adhesion (GO:0007157);lectin (GO:0005530);receptor activity (GO:0004872);sugar binding (GO:0005529)	C-type lectin (IPR001304);Hepatic lectin, N-terminal (IPR005640);Type II antifreeze protein (IPR002353)	
high	5.79121351473	210049_at	SERPINC1	AT3;ATIII;SERPINC1	serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1	blood coagulation (GO:0007596);heparin binding (GO:0008201);protein binding (GO:0005515);serine-type endopeptidase inhibitor activity (GO:0004867)	Proteinase inhibititor I4, serpin (IPR000215)	
high	5.50470609607	204713_s_at	F5	FVL;PCCF	coagulation factor V (proaccelerin, labile factor)	blood coagulation (GO:0007596);blood coagulation factor activity (GO:0003801);cell adhesion (GO:0007155);copper ion binding (GO:0005507)	Bipartite nuclear localization signal (IPR001472);Coagulation factor 5/8 type C domain (FA58C) (IPR000421);Cupredoxin (IPR008972);Galactose-binding like (IPR008979);Multicopper oxidase, type 1 (IPR001117)	
high	5.39993595905	gnf1h01345_at	gnf1h01345_at	None	None	None	None	
high	5.39780427695	210095_s_at	IGFBP3	IBP3;IGFBP3	insulin-like growth factor binding protein 3	cell growth and/or maintenance (GO:0008151);insulin-like growth factor binding (GO:0005520);metal ion binding (GO:0046872);negative regulation of signal transduction (GO:0009968);positive regulation of myoblast differentiation (GO:0045663);protein tyrosine phosphatase activator activity (GO:0008160);regulation of cell growth (GO:0001558);signal transduction (GO:0007165)	Bipartite nuclear localization signal (IPR001472);Growth factor, receptor (IPR009030);Insulin-like growth factor-binding protein, IGFBP (IPR000867);Thyroglobulin type-1 (IPR000716)	
high	5.38867907282	210327_s_at	AGXT	AGT;AGT1;AGXT;AGXT1;SPAT;SPT;TLH6	alanine-glyoxylate aminotransferase (oxalosis I; hyperoxaluria I; glycolicaciduria; serine-pyruvate aminotransferase)	alanine-glyoxylate transaminase activity (GO:0008453);metabolism (GO:0008152);serine-pyruvate transaminase activity (GO:0004760);transaminase activity (GO:0008483);transferase activity (GO:0016740)	Aminotransferase, class V (IPR000192);TONB Box N terminus (IPR010916)	
high	5.37956763745	204561_x_at	APOC2	APOC2	apolipoprotein C-II	circulation (GO:0008015);enzyme activator activity (GO:0008047);lipid catabolism (GO:0016042);lipid metabolism (GO:0006629);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);lipoprotein lipase activity (GO:0004465)	Apolipoprotein C-II (IPR008019)	
high	5.3413914626	219466_s_at	APOA2	APOA2	apolipoprotein A-II	glucose metabolism (GO:0006006);high-density lipoprotein (GO:0005321);lipid binding (GO:0008289);lipid catabolism (GO:0016042);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);neutrophil activation (GO:0042119);protein heterodimerization activity (GO:0046982);protein homodimerization activity (GO:0042803);response to glucose stimulus (GO:0009749)	Apolipoprotein A-II (ApoA-II) (IPR006801)	
high	5.2508036912	220266_s_at	KLF4	EZF;GKLF;KLF4	Kruppel-like factor 4 (gut)	negative regulation of cell proliferation (GO:0008285);nucleic acid binding (GO:0003676);transcription activating factor (GO:0003710);transcription factor activity (GO:0003700);transcriptional activator activity (GO:0016563);transcriptional repressor activity (GO:0016564);zinc ion binding (GO:0008270)	Proline-rich region (IPR000694);Zn-finger, C2H2 type (IPR007087)	
high	5.22289777249	209392_at	ENPP2	ATX;ENPP2;LysoPLD;PD-IALPHA;PDNP2	ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin)	G-protein coupled receptor protein signaling pathway (GO:0007186);cell motility (GO:0006928);chemotaxis (GO:0006935);endonuclease activity (GO:0004519);hydrolase activity (GO:0016787);nucleic acid binding (GO:0003676);nucleotide diphosphatase activity (GO:0004551);nucleotide metabolism (GO:0009117);phosphate metabolism (GO:0006796);phosphodiesterase I activity (GO:0004528);transcription factor binding (GO:0008134)	Bipartite nuclear localization signal (IPR001472);DNA/RNA non-specific endonuclease (IPR001604);Somatomedin B (IPR001212);Type I phosphodiesterase/nucleotide pyrophosphatase (IPR002591)	
high	5.21519964472	211548_s_at	HPGD	15-PGDH;HPGD;PGDH1	hydroxyprostaglandin dehydrogenase 15-(NAD)	15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404);catalytic activity (GO:0003824);electron transporter activity (GO:0005489);metabolism (GO:0008152);oxidoreductase activity (GO:0016491);prostaglandin metabolism (GO:0006693);prostaglandin-D synthase activity (GO:0004667)	2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (IPR003560);Glucose/ribitol dehydrogenase (IPR002347);Insect alcohol dehydrogenase family (IPR002424);Short-chain dehydrogenase/reductase SDR (IPR002198)	
high	5.14008646025	gnf1h06930_at	FLJ14490	FLJ14490	hypothetical protein FLJ14490	None	None	
high	5.12100698151	204450_x_at	APOA1	APOA1	apolipoprotein A-I	cholesterol metabolism (GO:0008203);circulation (GO:0008015);high-density lipoprotein (GO:0005321);high-density lipoprotein binding (GO:0008035);lipid binding (GO:0008289);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);lipoprotein metabolism (GO:0042157);structural molecule activity (GO:0005198)	Apolipoprotein A1/A4/E (IPR000074)	
high	5.10757799714	gnf1h09235_at	gnf1h09235_at	None	None	None	None	
high	5.0694107724	217073_x_at	APOA1	APOA1	apolipoprotein A-I	cholesterol metabolism (GO:0008203);circulation (GO:0008015);high-density lipoprotein (GO:0005321);high-density lipoprotein binding (GO:0008035);lipid binding (GO:0008289);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);lipoprotein metabolism (GO:0042157);structural molecule activity (GO:0005198)	Apolipoprotein A1/A4/E (IPR000074)	
high	5.06791694332	gnf1h08340_at	A1BG	A1B;A1BG;ABG;GAB	alpha-1-B glycoprotein	biological_process unknown (GO:0000004);molecular_function unknown (GO:0005554)	Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	4.94148966617	209975_at	CYP2E1	CPE1;CYP2E;CYP2E1;P450-J;P450C2E	cytochrome P450, family 2, subfamily E, polypeptide 1	cytochrome P450 activity (GO:0015034);electron transport (GO:0006118);monooxygenase activity (GO:0004497);oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen\, reduced flavin or flavoprotein as one donor\, and incorporation of one atom of oxygen (GO:0016712);oxygen binding (GO:0019825)	B-class P450 (IPR002397);Cytochrome P450 (IPR001128);E-class P450, CYP2E (IPR008070);E-class P450, group I (IPR002401);E-class P450, group IV (IPR002403)	
high	4.90056516368	gnf1h06148_at	C6orf170	C6orf170;FLJ30899;dJ310J6.1	chromosome 6 open reading frame 170	None	RabGAP/TBC domain (IPR000195)	
high	4.89450786248	220532_s_at	LR8	LR8	LR8 protein	histogenesis and organogenesis (GO:0007397);organogenesis (GO:0009887)	LR8 (IPR009281)	
high	4.87709180387	203865_s_at	ADARB1	ADAR2;ADARB1;DRABA2;DRADA2;RED1	adenosine deaminase, RNA-specific, B1 (RED1 homolog rat)	RNA binding (GO:0003723);RNA processing (GO:0006396);adenosine deaminase activity (GO:0004000);double-stranded RNA binding (GO:0003725);hydrolase activity (GO:0016787);mRNA processing (GO:0006397)	Adenosine deaminase/editase (IPR002466);Bipartite nuclear localization signal (IPR001472);Double-stranded RNA binding (DsRBD) domain (IPR001159)	
high	4.80993917475	212657_s_at	IL1RN	ICIL-1RA;IL1F3;IL1RA;IL1RN;IRAP;MGC10430	interleukin 1 receptor antagonist	immune response (GO:0006955);inflammatory response (GO:0006954);interleukin-1 receptor antagonist activity (GO:0005152)	Cytokine, IL-1 related (IPR008996);Interleukin-1 (IPR000975);Interleukin-1 receptor antagonist  IL1RA (IPR003297);Interleukin-1, alpha/beta (IPR003294);Interleukin-1, beta IL1B (IPR003296)	
high	4.77760442055	203381_s_at	APOE	APOE	apolipoprotein E	antioxidant activity (GO:0016209);apolipoprotein E receptor binding (GO:0050749);beta-amyloid binding (GO:0001540);cholesterol homeostasis (GO:0042632);cholesterol metabolism (GO:0008203);circulation (GO:0008015);cytoskeleton organization and biogenesis (GO:0007010);development (GO:0007275);heparin binding (GO:0008201);immune response (GO:0006955);intracellular transport (GO:0046907);learning and/or memory (GO:0007611);lipid binding (GO:0008289);lipid metabolism (GO:0006629);lipid transport (GO:0006869);lipid transporter activity (GO:0005319);lipoprotein metabolism (GO:0042157);low-density lipoprotein receptor binding (GO:0050750);plasma protein (GO:0005209);receptor binding (GO:0005102);response to reactive oxygen species (GO:0000302);tau protein binding (GO:0048156)	Apolipoprotein A1/A4/E (IPR000074)	
high	4.75374571454	214370_at	S100A8	60B8AG;CAGA;CFAG;CGLA;CP-10;L1Ag;MA387;MIF;MRP8;NIF;S100A8	S100 calcium binding protein A8 (calgranulin A)	calcium ion binding (GO:0005509);inflammatory response (GO:0006954)	Calcium-binding EF-hand (IPR002048);Calcium-binding protein, S-100/ICaBP type (IPR001751)	
high	4.6808611285	204379_s_at	FGFR3	ACH;CEK2;FGFR3;HSFGFR3EX;JTK4	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)	ATP binding (GO:0005524);JAK-STAT cascade (GO:0007259);MAPKKK cascade (GO:0000165);cell growth (GO:0016049);fibroblast growth factor receptor activity (GO:0005007);fibroblast growth factor receptor signaling pathway (GO:0008543);oncogenesis (GO:0007048);protein amino acid phosphorylation (GO:0006468);protein-tyrosine kinase activity (GO:0004713);receptor activity (GO:0004872);skeletal development (GO:0001501);transferase activity (GO:0016740)	Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Protein kinase (IPR000719);Serine/threonine protein kinase (IPR002290);Tyrosine protein kinase (IPR001245)	
high	4.66403272215	219554_at	RHCG	RHCG;RHGK	Rhesus blood group, C glycoprotein	ammonium transport (GO:0015696);ammonium transporter activity (GO:0008519);ankyrin binding (GO:0030506);cell growth and/or maintenance (GO:0008151);small molecule transport (GO:0006832);transport (GO:0006810);transporter activity (GO:0005215)	Ammonium transporter (IPR001905);Blood group Rhesus C/E and D polypeptide (IPR002229);Rh-like protein/ammonium transporter (IPR010256)	
high	4.66032852659	gnf1h01546_s_at	Hs.523212	None	Transcribed sequence	None	None	
high	4.63877891743	208791_at	CLU	APOJ;CLI;CLU;MGC24903;SGP-2;SGP2;SP-40;TRPM-2;TRPM2	clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J)	apoptosis (GO:0006915);cell death (GO:0008219);fertilization (sensu Animalia) (GO:0007338);lipid metabolism (GO:0006629);plasma glycoprotein (GO:0005211)	Bipartite nuclear localization signal (IPR001472);Clusterin (IPR000753)	
low	-4.97750433076	204018_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)	
low	-5.00627594262	gnf1h02627_s_at	KCNC2	KCNC2;KV3.2	potassium voltage-gated channel, Shaw-related subfamily, member 2	cation transport (GO:0006812);potassium ion transport (GO:0006813);protein binding (GO:0005515);voltage-gated potassium channel activity (GO:0005249)	BTB/POZ (IPR000210);Cation channel, non-ligand gated (IPR005820);Ion transport protein (IPR005821);K+ channel tetramerisation (IPR003131);K+ channel, pore region (IPR001622);Kv channel (IPR003968);Proline-rich region (IPR000694);Shaw voltage-gated K+ channel (IPR003974);Voltage-dependent potassium channel (IPR003091)	
low	-5.04313188405	216004_s_at	PKNOX1	PKNOX1;PREP1	PBX/knotted 1 homeobox 1	specific RNA polymerase II transcription factor activity (GO:0003704);transcription factor activity (GO:0003700)	Homeobox (IPR001356);Homeodomain-like (IPR009057)	
low	-5.04893588461	208651_x_at	CD24	CD24;CD24A	CD24 antigen (small cell lung carcinoma cluster 4 antigen)	humoral immune response (GO:0006959)	None	
low	-5.07105283082	203872_at	ACTA1	ACTA;ACTA1;ASMA;NEM1;NEM2	actin, alpha 1, skeletal muscle	motor activity (GO:0003774);muscle contraction (GO:0006936);muscle development (GO:0007517);structural constituent of cytoskeleton (GO:0005200)	Actin (IPR004001);Actin/actin-like (IPR004000)	
low	-5.09144704253	218788_s_at	SMYD3	FLJ21080;SMYD3;ZMYND1;ZNFN3A1	SET and MYND domain containing 3	None	Nuclear protein SET (IPR001214);TPR-like (IPR008941);Zn-finger, MYND type (IPR002893)	
low	-5.11678263932	204848_x_at	HBG1	HBG1;HBGA;HBGR	hemoglobin, gamma A	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);transport (GO:0006810)	Beta haemoglobin (IPR002337);Globin (IPR000971);Globin-like (IPR009050)	
low	-5.18014914642	214603_at	MAGEA2	MAGE2;MAGEA2;MAGEA2A;MAGEA2b;MGC16973	melanoma antigen, family A, 2	tumor antigen (GO:0008222)	Bipartite nuclear localization signal (IPR001472);MAGE protein (IPR002190)	
low	-5.20228645354	266_s_at	CD24	CD24;CD24A	CD24 antigen (small cell lung carcinoma cluster 4 antigen)	humoral immune response (GO:0006959)	None	
low	-5.22264067449	214974_x_at	CXCL5	CXCL5;ENA-78;SCYB5	chemokine (C-X-C motif) ligand 5	cell-cell signaling (GO:0007267);chemokine activity (GO:0008009);chemotaxis (GO:0006935);immune response (GO:0006955);inflammatory response (GO:0006954);positive regulation of cell proliferation (GO:0008284);signal transduction (GO:0007165)	Small chemokine, C-X-C subfamily (IPR001089);Small chemokine, C-X-C/Interleukin 8 (IPR002473);Small chemokine, interleukin-8 like (IPR001811)	
low	-5.23666726927	202620_s_at	PLOD2	PLOD2	procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2	oxidoreductase activity (GO:0016491);oxidoreductase activity\, acting on single donors with incorporation of molecular oxygen\, incorporation of two atoms of oxygen (GO:0016702);procollagen-lysine 5-dioxygenase activity (GO:0008475);protein metabolism (GO:0019538);protein modification (GO:0006464)	2OG-Fe(II) oxygenase superfamily (IPR005123);Procollagen-lysine 5-dioxygenase (IPR001006);Prolyl 4-hydroxylase, alpha subunit (IPR006620)	
low	-5.25152502373	209458_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)	
low	-5.26207484094	205589_at	MYL3	MLC1V;MYL3;VLC1	myosin, light polypeptide 3, alkali; ventricular, skeletal, slow	calcium ion binding (GO:0005509);muscle contraction (GO:0006936);muscle development (GO:0007517);structural constituent of muscle (GO:0008307)	Calcium-binding EF-hand (IPR002048)	
low	-5.26623403237	203863_at	ACTN2	ACTN2	actinin, alpha 2	actin binding (GO:0003779);calcium ion binding (GO:0005509);protein binding (GO:0005515);structural constituent of muscle (GO:0008307)	Actin-binding, actinin-type (IPR001589);Calcium-binding EF-hand (IPR002048);Calponin-like actin-binding (IPR001715)	
low	-5.26844210604	gnf1h09294_s_at	HBG1	HBG1;HBGA;HBGR	hemoglobin, gamma A	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);transport (GO:0006810)	Beta haemoglobin (IPR002337);Globin (IPR000971);Globin-like (IPR009050)	
low	-5.30864525551	205826_at	MYOM2	MYOM2;TTNAP	myomesin (M-protein) 2, 165kDa	muscle contraction (GO:0006936);muscle development (GO:0007517);striated muscle contraction (GO:0006941);structural constituent of muscle (GO:0008307)	Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-5.34756049691	205615_at	CPA1	CPA;CPA1	carboxypeptidase A1 (pancreatic)	carboxypeptidase A activity (GO:0004182);carboxypeptidase activity (GO:0004180);hydrolase activity (GO:0016787);metallopeptidase activity (GO:0008237);proteolysis and peptidolysis (GO:0006508)	Peptidase M14, carboxypeptidase A (IPR000834);Proteinase inhibitor,  carboxypeptidase propeptide (IPR003146);Proteinase inhibitor, propeptide (IPR009020)	
low	-5.37525115248	216470_x_at	216470_x_at	None	T cell receptor beta locus	None	None	
low	-5.39171198391	211745_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)	
low	-5.46400403158	204737_s_at	MYH7	CMH1;MYH7;MYHCB	myosin, heavy polypeptide 7, cardiac muscle, beta	ATP binding (GO:0005524);actin binding (GO:0003779);calmodulin binding (GO:0005516);microfilament motor activity (GO:0000146);motor activity (GO:0003774);muscle contraction (GO:0006936);muscle development (GO:0007517);protein amino acid alkylation (GO:0008213);striated muscle contraction (GO:0006941);structural constituent of muscle (GO:0008307)	IQ calmodulin-binding region (IPR000048);Myosin N-terminal SH3-like domain (IPR004009);Myosin head (motor domain) (IPR001609);Myosin tail (IPR002928);Tropomyosin (IPR000533)	
low	-5.47425602622	205942_s_at	SAH	SAH	SA hypertension-associated homolog (rat)	catalytic activity (GO:0003824);metabolism (GO:0008152);regulation of blood pressure (GO:0008217)	AMP-dependent synthetase and ligase (IPR000873);Amino acid adenylation (IPR010071);O-succinylbenzoate-CoA ligase (IPR010192)	
low	-5.49501011712	206834_at	HBD	HBD	hemoglobin, delta	globin (GO:0001524);oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);transport (GO:0006810)	Beta haemoglobin (IPR002337);Globin (IPR000971);Globin-like (IPR009050)	
low	-5.57526268095	214414_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)	
low	-5.61725811639	212070_at	GPR56	GPR56;TM7LN4;TM7XN1	G protein-coupled receptor 56	G-protein coupled receptor activity (GO:0004930);G-protein coupled receptor protein signaling pathway (GO:0007186);catalytic activity (GO:0003824);cell adhesion (GO:0007155);cell-cell signaling (GO:0007267);metabolism (GO:0008152);neuropeptide signaling pathway (GO:0007218);receptor activity (GO:0004872)	AMP-dependent synthetase and ligase (IPR000873);G-protein coupled receptor family 2 (secretin-like) (IPR000832);GPR56 orphan receptor (IPR003910);GPS domain (IPR000203)	
low	-5.70785019594	211699_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)	
low	-5.87169655044	206446_s_at	ELA2A	ELA2A	elastase 2A	chymotrypsin activity (GO:0004263);hydrolase activity (GO:0016787);pancreatic elastase II activity (GO:0004281);pancreatic elastase activity (GO:0008132);proteolysis and peptidolysis (GO:0006508);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-5.92192900026	205402_x_at	PRSS2	PRSS1;PRSS2;TRP1;TRY1;TRY2;TRY4;TRY8;TRYP1;TRYP2	protease, serine, 2 (trypsin 2)	calcium ion binding (GO:0005509);chymotrypsin activity (GO:0004263);digestion (GO:0007586);hydrolase activity (GO:0016787);peptidase activity (GO:0008233);proteolysis and peptidolysis (GO:0006508);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-5.96951221686	209700_x_at	PDE4DIP	CMYA2;KIAA0454;KIAA0477;MMGL;PDE4DIP	phosphodiesterase 4D interacting protein (myomegalin)	None	None	
low	-6.28619197371	205869_at	PRSS2	PRSS1;PRSS2;TRP1;TRY1;TRY2;TRY4;TRY8;TRYP1;TRYP2	protease, serine, 2 (trypsin 2)	calcium ion binding (GO:0005509);chymotrypsin activity (GO:0004263);digestion (GO:0007586);hydrolase activity (GO:0016787);peptidase activity (GO:0008233);proteolysis and peptidolysis (GO:0006508);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-6.4833917735	209771_x_at	CD24	CD24;CD24A	CD24 antigen (small cell lung carcinoma cluster 4 antigen)	humoral immune response (GO:0006959)	None	
low	-6.63797565279	206422_at	GCG	GCG;GLP1;GLP2;GRPP	glucagon	G-protein coupled receptor protein signaling pathway (GO:0007186);cell proliferation (GO:0008283);feeding behavior (GO:0007631);hormone activity (GO:0005179);peptide hormone (GO:0005180);receptor binding (GO:0005102);signal transduction (GO:0007165)	Bipartite nuclear localization signal (IPR001472)	
low	-6.77326568825	209116_x_at	HBB	HBB	hemoglobin, beta	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);transport (GO:0006810)	Beta haemoglobin (IPR002337);Globin (IPR000971);Globin-like (IPR009050);Myoglobin (IPR002335)	
low	-6.77590212828	219196_at	SCG3	SCG3;SGIII	secretogranin III	chemotaxis (GO:0006935);signal transduction (GO:0007165);transmembrane receptor activity (GO:0004888)	None	
low	-7.06182640456	205910_s_at	CEL	BAL;BSDL;BSSL;CEL;CELL;CEase;FAP;FAPP;LIPA	carboxyl ester lipase (bile salt-stimulated lipase)	catalytic activity (GO:0003824);cell differentiation (GO:0030154);cell growth (GO:0016049);cholesterol catabolism (GO:0006707);fat-soluble vitamin catabolism (GO:0042363);hydrolase activity (GO:0016787);lipase activity (GO:0016298);lipid catabolism (GO:0016042);lipid metabolism (GO:0006629);protein binding (GO:0005515);serine esterase activity (GO:0004759);sterol esterase activity (GO:0004771)	Carboxylesterase, type B (IPR002018);Cholinesterase (IPR000997);Esterase/lipase/thioesterase (IPR000379);Proline-rich region (IPR000694)	
low	-7.26199214733	217414_x_at	HBA2	HBA1;HBA2	hemoglobin, alpha 2	oxygen transport (GO:0015671);oxygen transporter activity (GO:0005344);protein binding (GO:0005515);transport (GO:0006810)	Alpha haemoglobin (IPR002338);Globin (IPR000971);Globin-like (IPR009050);Pi haemoglobin (IPR002339)